1:00pm - 2:00pm Wednesday, March 11

Location & Room

Orlando - Orange County Convention Center
W204A

Global cyberattacks like Wannacry have highlighted the need for more robust cybersecurity preparedness to ensure a real-time response that enables continuity of clinical operations. In addition, it is important to come to ground truth when high consequence vulnerabilities are discovered in medical devices. The FDA, in partnership with the MITRE Corporation, has championed two initiatives to improve medical device cybersecurity preparedness and response: (1) the development and use of a medical device cybersecurity sandbox to enable security research and technical evaluation of medical device vulnerabilities and potential mitigations across Health Delivery Organizations, medical device manufacturers, and the FDA, and (2) the exploration of the viability and execution of a CyberMed Safety Analysis Board to integrate critical patient safety and clinical environment dimensions into the assessment and validation of high-risk/high-impact device vulnerabilities and incidents.

Speakers: 
Director, Office of Strategic Partnerships & Technology Innovation, Center for Devices and Radiological Health (CDRH),
Food and Drug Administration (FDA)
Senior Principal Cybersecurity Engineer,
The MITRE Corporation
Continuing Education Credits: 
ABPM
1.00
CAHIMS
1.00
CME
1.00
CNE
1.00
CPHIMS
1.00
IAPP
1.00